Document is current

Any future updates will be listed below

An Estimate of the Benefit-Cost Impact of the FDA Guidance on Data Monitoring Committees

Crossref DOI link: https://doi.org/10.1177/2168479015573586

Published Online: 2015-12-30

Published Print: 2015-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark